Researchers successfully treat congenital disease in unborn mice via drug delivery to amniotic fluid.

Congenital disease, estimated to cause the death of 276,000 infants within the first month of life each year across the globe, also causes childhood illness and long-term disability. Prenatal screening techniques now make early diagnosis possible, presenting the opportunity to intervene in disease processes before birth.  Now, a study from researchers led by Rosalind Franklin University shows that antisense oligonucleotides (ASOs), short strands of engineered … Continue reading Researchers successfully treat congenital disease in unborn mice via drug delivery to amniotic fluid.